ZBiotics key facts
as of Oct 2026- Developer of genetically engineered probiotics designed to improve the body's ability to break down unwanted byproducts of alcohol to convert sugar into fiber in the gut.
- ZBiotics is valued at approximately $67.0M as of Oct 2026, set at its later-stage round, Aug 2024; nothing has traded since, per PrivateMarketView’s mark.
- It has raised $40.3M across 2 recorded rounds; the latest was Early Stage VC ($22.4M) in Mar 2024.
- Notable investors include Plug and Play Tech Center, Y Combinator, FJ Labs, Pareto Holdings, Kevin Moore — 34 tracked in total.
- ZBiotics has filed 2 Form Ds with the SEC since 2020, most recently Apr 2024 ($22.4M sold to 68 investors).
- Status: Privately Held (backing).
Valued at $67.0M at its later-stage round, Aug 2024. Nothing has traded since.
- ·The complete investor list: 34 names
- ·Watch ZBiotics: the Monday email on marks, rounds and moves
ZBiotics funding rounds
2 roundsWho backs ZBiotics
34+ZBiotics valuation
ZBiotics was valued at $67 million at its later-stage round in Aug 2024. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has ZBiotics raised?
ZBiotics has raised $40.3 million in total; 2 of its rounds are on record. The largest on record was a $5.7 million early-stage round in Mar 2020; the most recent was a $22.4 million early-stage round in Mar 2024.
ZBiotics has filed 2 Form Ds with the SEC since 2020, most recently in Apr 2024 ($22.4 million sold to 68 investors).
ZBiotics investors
34 investors are on record for ZBiotics, including Plug and Play Tech Center, Y Combinator, FJ Labs and Pareto Holdings. By type, the record holds 5 venture capital firms, 2 family offices and 2 growth equity firms. The early-stage round in Mar 2024 drew 68 investors.
About ZBiotics
Developer of genetically engineered probiotics designed to improve the body's ability to break down unwanted byproducts of alcohol to convert sugar into fiber in the gut. The company offers a probiotic drink that breaks down acetaldehyde, an undesirable byproduct of alcohol, enabling users to prevent the worst next-day effects of drinking.
- Sector
- Consumer Products and Services (B2C)
- HQ
- San Francisco, CA, United States
- Founded
- 2016
- Employees
- 48
- Website
- zbiotics.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.